The North America Bioreactors Market size was valued at USD 470.13 Million in 2022 and estimated to be growing at a CAGR of 6.35% to reach USD 639.60 Million by 2027.
Manufacture or production of enzymes, biologically active ingredients like yeast, and other materials require special processing plants that support the biologically active environment. These types of reactors are termed bioreactors. These devices have enormous applications in biochemical engineering, tissue engineering, drug designing, and development. Rising Chronic disease prevalence and increasing biopharmaceutical investments will propel the growth of the market.
North America recently completed municipal corporation projects in the United States and now has substantial new opportunities in several verticals such as food & beverages, hospital, oil refinery, etc. These are estimated to favor the bioreactor market in this region. North American market players develop new designs for bioreactors for customers' demand.
Bioreactor suppliers in North America are Mitsubishi, Rayon, Kubota had the most installed plants in the region. In North America, bioreactors are mostly used for wastewater treatment. Government investing in research and development projects to raise the market. Single-use bioreactor demand for the product in the pharmaceutical industry is leading towards the cell culture storages; it will increase the number of bioreactors.
The primary growth drivers are responsible for the growth of the market increase in the incidence of lifestyle diseases like diabetes and cancer, rising biopharmaceutical investments, increasing chronic disease prevalence, increasing demand for therapeutically active vaccines, product innovation, and favorable government initiatives to develop healthcare infrastructure. Also, factors such as the growing personalized medicine market and increasing popularity for them, increasing the demand for single-use bioreactors among the biopharmaceutical companies will assist the market's growth.
Yet, regulatory issues regarding single-use bioreactors, limited storage, and vulnerability to leaching may hinder the market's growth. Furthermore, large scale disposal of plastic derivatives is an environmental concern restraining the growth.
This research report on the North America Bioreactors Market has been segmented and sub-segmented the North America Bioreactors Market into the following categories:
By Production Size:
By Control Type:
By End Users:
Regionally, the United States Bioreactors market is leading the North American market, increasing financial support for the development of innovative drugs, and an increase in no. of biopharmaceutical manufacturers has propelled the growth of the market. The United States Bioreactors Market is also expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure, awareness, and rapid medical and technological advancements. CMO’s are the major players in terms of end-users. Single-use bioreactors are the most widely used ones with a 41% share. Glass bioreactors are majorly used for R&D.
The Canadian bioreactors market is estimated to witness a healthy CAGR due to a well-developed manufacturing infrastructure, which is expected to boost bioreactor production growth. The Canada based bioreactor companies focus on new product launches, collaboration to stay in competition & expansion of the market. A significant rise in bioreactors for agricultural ingredients, products & drugs for the specific disease will help raise agricultural products with the bioreactors market. Government initiatives such as investments and subsidies increase economic growth to stimulate market demand in the near future.
Key Market Participants Leading the North America Bioreactors Market Profiled in the Report are Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, and significant Engineering, Procurement and Construction (EPC) players included in this report are Amec Foster Wheeler plc., Fluor Corporation, Jacobs Engineering Group Inc., M+W Group, PM Group, and Technip S.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org